chalcone has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, XX; Liang, G; Mei, YN; Shen, Z; Xing, SH; Yang, HM; Zheng, XH; Zhu, JF | 1 |
| Astuti, I; Bamodu, OA; Huang, WC; Lee, WH; Lin, CM; Su, YK; Suwito, H; Yeh, CT; Zucha, MA | 1 |
2 other study(ies) available for chalcone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
Topics: Apoptosis; Benzaldehydes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Chalcones; Cytoskeletal Proteins; Cytoskeleton; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Recurrence, Local; Phosphorylation; STAT3 Transcription Factor; Triple Negative Breast Neoplasms | 2022 |
Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication.
Topics: Apoptosis; Autophagy; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Chalcone; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Phosphorylation | 2017 |